Prostate News Archive
04-May-2011
Prostate Cancer Drug Roars Ahead
Johnson & Johnson's buy of Cougar paid off, but look in the rearview mirror. FDA Approves Prostate Cancer Drug Zytiga
Title: FDA Approves prostate Cancer Drug Zytiga Category: Health News Created: 4/29/2011 11:01:00 AM Last Editorial Review: 4/29/2011 In Prostate Cancer Patients Aspirin Found To Reduce The Risk Of Cancer Recurrence
Some studies have shown that blood-thinning medications, such as aspirin, can reduce biochemical failure - cancer recurrence that is detected by a rising prostate-specific antigen (PSA) level - the risk of metastasis and even death in localized prostate cancer. These studies, although very telling, have all emphasized the need for more data. Now, with researchers at Fox Chase Cancer Center ... Investigational Agent Shows Promise In Reducing Spread Of Prostate Cancer
A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, as seen in new lab studies say researchers at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center (GUMC). Published online April 29 in PLoS ONE, the researchers report that if the agent continues to work well in further ... Zytiga Approved for Advanced Prostate Cancer
FRIDAY, April 29 (HealthDay News) -- Zytiga (abiraterone acetate), used in combination with the steroid prednisone, has been approved to treat advanced prostate cancer, the U.S. Food and Drug Administration said in a news release.
Back to Prostate News Archive
